Vikramjit K Zhawar1, Raj P Kandpal2, Raghbir S Athwal3. 1. Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA, U.S.A. 2. Department of Basic Medical Sciences, Western University of Health Sciences, Pomona, CA, U.S.A. rathwal@temple.edu rkandpal@westernu.edu. 3. Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA, U.S.A. rathwal@temple.edu rkandpal@westernu.edu.
Abstract
BACKGROUND/AIM: Glutamate receptor GRIK2, previously designated as GluR6, is best described in neuronal cells. However, its biological relevance in non-neuronal cells is not well understood. We have investigated the expression of this important protein in normal human fibroblasts as a function of cell proliferation. MATERIALS AND METHODS: We introduced expression constructs of all five isoforms (A-E) of GRIK2 in normal human fibroblasts and investigated the cells for the presence and localization of GRIK2, as well as for cell proliferation and senescence over a period of 24 days. RESULTS: The expression of GRIK2-A isoform led to immediate cessation of cell proliferation. However, the cell numbers increased by 1.5- to 9.0-fold in 24 days upon transfection with B, C, D and E isoforms, after which they entered a state of senescence. The decreased proliferation was reflected by incorporation of BrdU in only 2-8% of transfected cells even after culturing them for 16 days. CONCLUSION: Our results are indicative of an association between GRIK2 and aging of fibroblasts. Copyright
BACKGROUND/AIM: Glutamate receptor GRIK2, previously designated as GluR6, is best described in neuronal cells. However, its biological relevance in non-neuronal cells is not well understood. We have investigated the expression of this important protein in normal human fibroblasts as a function of cell proliferation. MATERIALS AND METHODS: We introduced expression constructs of all five isoforms (A-E) of GRIK2 in normal human fibroblasts and investigated the cells for the presence and localization of GRIK2, as well as for cell proliferation and senescence over a period of 24 days. RESULTS: The expression of GRIK2-A isoform led to immediate cessation of cell proliferation. However, the cell numbers increased by 1.5- to 9.0-fold in 24 days upon transfection with B, C, D and E isoforms, after which they entered a state of senescence. The decreased proliferation was reflected by incorporation of BrdU in only 2-8% of transfected cells even after culturing them for 16 days. CONCLUSION: Our results are indicative of an association between GRIK2 and aging of fibroblasts. Copyright
Authors: Françoise Coussen; David Perrais; Frédéric Jaskolski; Shankar Sachidhanandam; Elisabeth Normand; Joel Bockaert; Philippe Marin; Christophe Mulle Journal: Neuron Date: 2005-08-18 Impact factor: 17.173
Authors: Neena S Rane; Arbansjit K Sandhu; Vikramjit S Zhawar; Gurpreet Kaur; Nicholas C Popescu; Raj P Kandpal; Meena Jhanwar-Uniyal; Raghbir S Athwal Journal: Cancer Genomics Proteomics Date: 2011 Sep-Oct Impact factor: 4.069
Authors: F Acquati; C Morelli; R Cinquetti; M G Bianchi; D Porrini; L Varesco; V Gismondi; R Rocchetti; S Talevi; L Possati; C Magnanini; M G Tibiletti; B Bernasconi; M G Daidone; V Shridhar; D I Smith; M Negrini; G Barbanti-Brodano; R Taramelli Journal: Oncogene Date: 2001-02-22 Impact factor: 9.867
Authors: Vikramjit K Zhawar; Gurpreet Kaur; Jon K deRiel; G Pal Kaur; Raj P Kandpal; Raghbir S Athwal Journal: Gene Date: 2010-03-15 Impact factor: 3.688
Authors: Raj P Kandpal; Arbans K Sandhu; Gurpreet Kaur; Gursurinder P Kaur; Raghbir S Athwal Journal: Cancer Genomics Proteomics Date: 2017 Mar-Apr Impact factor: 4.069